0001209191-15-069484.txt : 20150903
0001209191-15-069484.hdr.sgml : 20150903
20150903171708
ACCESSION NUMBER: 0001209191-15-069484
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150901
FILED AS OF DATE: 20150903
DATE AS OF CHANGE: 20150903
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TETRAPHASE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001373707
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 480 ARSENAL STREET
STREET 2: SUITE 110
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617.715.3600
MAIL ADDRESS:
STREET 1: 480 ARSENAL STREET
STREET 2: SUITE 110
CITY: WATERTOWN
STATE: MA
ZIP: 02472
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Macdonald Guy
CENTRAL INDEX KEY: 0001296998
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35837
FILM NUMBER: 151092741
MAIL ADDRESS:
STREET 1: C/O IDENIX PHARMACEUTICALS, INC.
STREET 2: 60 HAMPSHIRE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-09-01
0
0001373707
TETRAPHASE PHARMACEUTICALS INC
TTPH
0001296998
Macdonald Guy
480 ARSENAL ST. SUITE 110
WATERTOWN
MA
02472
1
1
0
0
President and Chief Executive
Common Stock
2015-09-01
4
M
0
10000
7.94
A
62000
D
Common Stock
2015-09-01
4
S
0
10000
41.57
D
52000
D
Employee Stock Option (right to buy)
7.94
2015-09-01
4
M
0
10000
0.00
D
2023-05-14
Common Stock
10000
180000
D
The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 25, 2014.
The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $40.51 to $43.34 per share. The reporting person herby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission,the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Vests as to 25% of the original number of shares granted on 5/15/2014 and further vests as to an additional 6.25% of the original number of shares granted at the end of each successive three-month period thereafter until 5/15/2017.
/s/Maria Stahl as Attorney-in-Fact for Guy Macdonald
2015-09-03